Weight Loss Drugs' Risks: Bone & Tendon Issues

0:00It's March 22nd. This is entertainment and celebrity news today, powered by AI, your front row to the latest buzz. I'm Cory with the story. Experts are raising alarms about popular weight loss drugs like ozimpic, wegovii, manjaro, and zepbound. New research shows these GLP1 medications, which mimic a hormone to curb appetite and control blood sugar, might increase risks for bone problems, and tendon injuries. A study reviewed health records from nearly 150,000 patients over five years. The findings point to specific dangers. Users face almost a 30% higher chance of osteoporosis, which weakens bones and raises fracture risks. Gout, a painful joint inflammation, went up by 12% while osteomalacia or bone softening surged by more than 150%. Tendon ruptures, like those in the rotator cuff or Achilles, rose by about 50%. These issues had harder for certain groups.

1:00Older adults and postmanopausal women could face serious fallout, as fractures often lead to ongoing health troubles that are hard to shake. Doctors note that while the overall population risks stays low, individual cases can turn life altering. Researchers link the problems to rapid weight loss throwing off the balance in bones, muscles, and tendons. Hormonal shifts from the drugs and possible nutrient shorefalls during appetite suppression likely play a role too. Hormocompanies behind the shots stress patient safety as their top focus. Physicians remind us these drugs still bring big wins, like better blood sugar and heart health. The key takeaway is close monitoring and smart lifestyle tweaks to offset any downsides.